We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Names ODS Director, Unveils Details of CDER Reorganization
FDA Names ODS Director, Unveils Details of CDER Reorganization
October 21, 2005
Following a "broad" four-month nationwide search, the FDA has selected an internal candidate to fill the long-vacated director position in its Office of Drug Safety (ODS), the agency announced Oct. 19.